Glial–Neuronal Interactions are Impaired in the Schizophrenia Model of Repeated MK801 Exposure
- 14 December 2005
- journal article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 31 (9), 1880-1887
- https://doi.org/10.1038/sj.npp.1300993
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801Journal of Neurochemistry, 2005
- Schizophrenia: From Dopamine to Glutamate and BackCurrent Medicinal Chemistry, 2004
- Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- N-Acetylaspartate in the Vertebrate Brain: Metabolism and FunctionNeurochemical Research, 2003
- Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New EvidenceAnnual Review of Pharmacology and Toxicology, 2001
- Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivoEuropean Journal of Neuroscience, 2000
- Parallel Recovery of MK-801–Induced Spatial Learning Impairment and Neuronal Injury in Male MicePharmacology Biochemistry and Behavior, 1999
- Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)Journal of Neural Transmission, 1993
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal of Neural Transmission, 1989